Kelly Willenberg, DBA, RN, CCRP, CHRC, CHC is one of CITI Program’s expert contributors in clinical trial billing. As a respected expert in the research…
According to the authors of a recently published article in the New England Journal of Medicine, findings from the Adaptive COVID-19 Treatment Trial, support remdesivir…
At 12 PM ET on Thursday, June 18, CTTI will host Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials. The webinar will…
In an NIH clinical trial involving 1063 patients with advanced COVID-19, preliminary results indicate that those who received broad-spectrum antiviral treatment Remdesivir recovered 31% faster…
In recent weeks biotech and clinical research communities have pivoted resources toward developing vaccines against SARS-CoV-2. Teams around the world are researching various methods of…
Charles Hennekens, MD, DrPH is one of the expert authors of CITI Program’s Essentials of Public Health Research course. As a respected expert on public…
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency was released in March for industry, investigators, and institutional review…
This clinical trial will test the safety and efficacy of a treatment regimen of the remdesivir plus the anti-inflammatory drug baricitinib for COVID-19. It is…
A new NIH study will analyze blood samples from up to 10,000 volunteers without confirmed cases of COVID-19 for the presence of antibodies to the…
On April 8, 2020, the Office for Human Research Protections (OHRP) issued guidance on the regulatory requirements of 45 CFR 46 and actions taken during…
Although most research is paused during the global pandemic, there are new COVID-19 research studies starting every day. During this time, organizations may need to…
An article this week in Wired Magazine outlined how physicians and other health care providers in hospitals are using technology to manage patient care in…
